Home Press Release Glenmark’s La Shield® Shines Bright, Wins Best Consumer Healthcare Digital Marketing Campaign Award

Glenmark’s La Shield® Shines Bright, Wins Best Consumer Healthcare Digital Marketing Campaign Award

Glenmark’s La Shield® Shines Bright, Wins Best Consumer Healthcare Digital Marketing Campaign Award

Press Note                                                                                  For Immediate Release 

Glenmark’s La Shield® Shines Bright, 

Wins Best Consumer Healthcare Digital Marketing Campaign Award

  • La Shield’s ‘BE Sun wise’ Campaign used an innovative approach in educating consumers in being safe while exposed to the Sun for a prolonged time period. 
  • The award celebrates Glenmark’s commitment towards empowering customers towards making an informed choice while choosing their sunscreen.

India, November 08, 2023: Glenmark Pharmaceuticals Limited (Glenmark), a research-led, global pharmaceutical company announced that its skincare brand, La Shield®, has been honored with the “Best Consumer Healthcare Digital Marketing Campaign” award at the recently concluded Organization of Pharmaceutical Producers of India (OPPI) OTC Health and Wellness Conference 2023.

This accolade recognized La Shield®’s innovative and impactful digital marketing strategy. The campaign ‘Be Sun wise’ leveraged the available online information through dynamic creative optimization to provide consumers with relevant, real-time, city-specific UV index data. This science-backed, information-centric approach has set new standards in consumer awareness and brand adoption.

Highlighting the significance of this recognition, Mr. Alok Malik, President and Head of India Formulations Business at Glenmark Pharmaceuticals Ltd., commented, “We are deeply honored to receive this award. At Glenmark, our commitment towards customer empowerment consistently fuels our endeavors. The recognition for La Shield® is a testament to our initiative of promoting informed decision-making amongst consumers. Through this award-winning campaign, we successfully delivered palatable, crucial data to our users, empowering them to make smart decisions concerning their skin health. This award further instills our resolution to discover novel ways of engaging with our customers.”

The success of La Shield®’s digital marketing initiative underlines Glenmark Pharmaceuticals’ dedication to pioneering advancements in skincare and its continuous efforts to prioritize consumer well-being through science-backed solutions. The OPPI award underscores Glenmark’s commitment to sustainable innovation and customer-centricity, reinforcing its standing as a leader in the consumer healthcare domain. La Shield® offers a unique line of products well-regarded by dermatologists and consumers alike. Staying true to its commitments, La Shield® aims to provide comprehensive skincare protection against environmental stressors including UV radiation, pollution, smoke and dust.

The OPPI OTC Health and Wellness Conference is organized with the objective of promoting responsible self-care among individuals. The conference aims to empower consumers by providing them with evidence-based information on the appropriate use and safety of over the counter (OTC) medications. The platform celebrates leading healthcare and pharma innovators, honoring them for their exceptional contributions in consumer healthcare.

About OPPI

The Organization of Pharmaceutical Producers of India (OPPI) established in 1965, represents the research-based global pharmaceutical companies in India. OPPI has been an integral part of the healthcare journey of the country. The organization remains committed to supporting the nation’s healthcare objectives, putting patients at the core of all decision making and collaborating with all stakeholders to find sustainable solutions to realize the collective vision of Health for All.

OPPI’s member companies have been serving the country’s healthcare ecosystem since pre-independence and continue to remain committed to patient safety and providing quality care in the future as well. As an association, the company’s advocacy decisions, patient commitment, and work are always keeping the country first and embody the spirit of working for ‘Bharat Ke Liye’; driven by innovation to find solutions for unmet medical needs, collaboration with government stakeholders, and co-creation with partners coming together to address the nation’s healthcare challenges. OPPI is committed to the Hon’ble Prime Minister Shri Narendra Modi ji’s clarion call of ‘Jai Vigyan and Jai Anusandhan’.

About Glenmark Pharmaceuticals Limited

Glenmark Pharmaceuticals Limited (BSE: 532296 | NSE: GLENMARK) is an integrated, research‐led, global pharmaceutical company, having a presence across Branded, Generics, and OTC segments; with a focus on therapeutic areas of respiratory, dermatology and oncology. The company has 10 world-class manufacturing facilities spread across 4 continents, and operations in over 80 countries. In Vivo/Scrip 100 positions Glenmark amongst the Top 100 Companies Ranked by R&D and Pharmaceutical Sales, 2021; while Generics Bulletin/In Vivo places it in the Top 50 Generics and Biosimilars Companies Ranked by Sales, 2021. The company has also been Great Place To Work® Certified™ in India. Glenmark’s Green House Gas (GHG) emission reduction targets have been approved in 2023 by the Science Based Target initiative (SBTi), becoming the second Indian Pharmaceuticals company to achieve this approval. The organization has impacted over 2.9 million lives over the last decade through its CSR interventions. For more information, visit www.glenmarkpharma.com. You can follow us on LinkedIn (Glenmark Pharmaceuticals) and Instagram (glenmark_pharma).


Please enter your comment!
Please enter your name here